Anvisa publishes a new procedure for medicines

Medicamentos que fazem parte do novo procedimento da Anvisa

Anvisa publishes a new procedure for medicines

Brazil’s Anvisa (National Health Surveillance Agency) has published a new standard operating procedure for Medicines, according to RDC 823/2023. The measure aims to reduce requirements for companies by 30%, focusing on quality in the registration and post-registration changes of synthetic and semi-synthetic medicines. Read more here

If you need more information about the regularization of your medicines, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

I want to speak to a Specialist

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.

I want to speak to a Specialist